Psychiatry Research
Volume 125, Issue 3 , Pages 237-245 , 15 March 2004

Sensory gating deficit in a subtype of chronic schizophrenic patients

Received 3 April 2003 ,Revised 7 January 2004 ,Accepted 12 January 2004.

References 

  1. Adler LE, Hoffer LD, Griffith JM, Waldo MC, Freedman R. Normalisation by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biological Psychiatry. 1992;32:607–616
  2. Adler LE, Hoffer LD, Wiser A, Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. American Journal of Psychiatry. 1993;150:1856–1861
  3. Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R. Neurophysiological evidence for a deficit in neuronal mechanisms involved in sensory gating in schizophrenia. Biological Psychiatry. 1982;17:639–654
  4. Adler LE, Waldo MC, Tatcher A, Cawthra E, Baker N, Freedman R. Lack of relationship of auditory gating defects to negative symptoms in schizophrenia. Schizophrenia Research. 1990;3:131–138
  5. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Author, Washington DC
  6. Andreasen NC. Negative symptoms in schizophrenia. Archives of General Psychiatry. 1982;39:784–788
  7. Andreasen NC, Olsen S. Negative vs. positive schizophrenia. Archives of General Psychiatry. 1982;39:789–794
  8. Baker N, Adler LE, Franks RD, Waldo M, Berry S, Nagamoto H, et al. Neurophysiological asessment of sensory gating in psychiatric inpatients: comparison between schizophrenia and other diagnoses. Biological Psychiatry. 1987;22:603–617
  9. Baker NJ, Staunton N, Adler LE, Gerhardt GA, Drebing C, Waldo M, et al. Sensory gating deficits in psychiatric inpatients: relation to catecholamine metabolites in different diagnostic groups. Biological Psychiatry. 1990;27:519–528
  10. Birbaumer N, Schmidt RF. Biologische Psychologie. 3rd edn. Berlin: Springer-Verlag; 1996;
  11. Boutros NN, Belger A, Campbell D, D'Souza C, Krystal J. Comparison of four components of sensory gating in schizophrenia and normal subjects: a preliminary report. Psychiatry Research. 1999;88:119–130
  12. Boutros NN, Zouridakis G, Rustin T, Peabody C, Warner D. The P50 component of the auditory evoked potential and subtypes of schizophrenia. Psychiatry Research. 1993;47:243–254
  13. Braff DL, Geyer MA. Sensorimotor gating and schizophrenia: human and animal model studies. Archives of General Psychiatry. 1990;47:181–188
  14. Cadenhead KS, Light GA, Geyer MA, Braff DL. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. American Journal of Psychiatry. 2000;157:55–59
  15. Cardenas VA, Gerson J, Fein G. The reliability of P50 suppression as measured by the conditioning/testing ratio is vastly improved by dipole modelling. Biological Psychiatry. 1993;33:335–344
  16. Clementz BA, Geyer MA, Braff DL. P50 Suppression among schizophrenia and normal comparison subjects: a methodological analysis. Biological Psychiatry. 1997;41:1035–1044
  17. Clementz BA, Geyer MA, Braff DL. Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. American Journal of Psychiatry. 1998;155:1691–1694
  18. Cullum CM, Harris JG, Waldo MC, Smernoff E, Madison A, Nagamoto HT, et al. Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia. Schizophrenia Research. 1993;10:131–141
  19. Franks R, Adler LE, Waldo MC, Alpert J, Freedman R. Neurophysiological studies of sensory gating in mania: comparison with schizophrenia. Biological Psychiatry. 1983;18:989–1005
  20. Freedman R, Adler LE, Myles-Worsley M, Nagamoto HT, Miller C, Kisley M, et al. Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects: human recordings, computer simulation, and an animal model. Archives of General Psychiatry. 1996;53:1114–1121
  21. Freedman R, Adler LE, Waldo MC. Gating of the auditory evoked potential in children and adults. Psychophysiology. 1987;24:223–227
  22. Freedman R, Adler LE, Gerhardt GA, Waldo MC, Baker N, Rose GM, et al. Neurobiological studies of sensory gating in schizophrenia. Schizophrenia Bulletin. 1987;13:669–678
  23. Freedman R, Adler LE, Waldo MC, Pachtman E, Franks RD. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. Biological Psychiatry. 1982;18:537–551
  24. Freedman R, Waldo MC, Bickford-Wimer PC, Nagamoto HT. Elementary neuronal dysfunctions in schizophrenia. Schizophrenia Research. 1991;4:233–243
  25. Griffith JM, O'Neill JE, Petty F, Garver D, Young D, Freedman R. Nicotinic receptor desensitization and sensory gating deficits in schizophrenia. Biological Psychiatry. 1998;44:98–106
  26. Hetrick WP, Sandman CA, Bunney WE, Jin Y, Potkin SG, White MH. Gender differences in gating of the auditory evoked potential in normal subjects. Biological Psychiatry. 1996;39:51–58
  27. Jin Y, Bunney WE, Sandman CA, Patterson JV, Fleming K, Moenter JR, et al. Is P50 suppression a measure of sensory gating in schizophrenia?. Biological Psychiatry. 1998;43:873–878
  28. Jin Y, Potkin SG, Patterson JV, Sandman CA, Hetrick WP, Bunney WE. Effects of P50 temporal variability on sensory gating in schizophrenia. Psychiatry Research. 1997;70:71–81
  29. Kathmann N, Engel RR. Sensory gating in normals and schizophrenics: a failure to find strong P50 suppression in normals. Biological Psychiatry. 1990;27:1216–1226
  30. Leonhard K, Hrsg Beckmann H. Aufteilung der Endogenen Psychosen und ihre Differenzierte Ätiologie. Stuttgart: Thieme-Verlag; 1995;
  31. Light GA, Geyer MA, Clementz BA, Cadenhead KS, Braff DL. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. American Journal of Psychiatry. 2000;157:767–771
  32. McGhie A, Chapman J. Disorders of attention and perception in early schizophrenia. British Journal of Medical Psychology. 1961;34:103–116
  33. Myles-Worsley M, Coon H, Byerley W, Waldo MC, Young D, Freedman R. Developmental and genetic influences on the P50 sensory gating phenotype. Biological Psychiatry. 1996;39:289–295
  34. Nagamoto HT, Adler LE, Hea RA, Griffith JM, McRae K, Freedman R. Gating of auditory P50 in schizophrenics: unique effects of clozapine. Biological Psychiatry. 1996;40:181–188
  35. Nagamoto HT, Adler LE, Waldo MC, Freedman R. Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval. Biological Psychiatry. 1989;25:549–561
  36. Nagamoto HT, Adler LE, Waldo MC, Griffith JM, Freedman R. Gating of auditory response in schizophrenics and normal controls; effects of recording site and stimulation interval on the P50 wave. Schizophrenia Research. 1991;4:31–40
  37. Siegel C, Waldo MC, Mizner G, Adler LE, Freedman R. Deficits in sensory gating in schizophrenic patients and their relatives. evidence obtained with auditory evoked responses. Archives of General Psychiatry. 1984;41:607–612
  38. Vinogradov S, Solomon S, Ober BA, Biggins CA, Shenaut GK, Fein G. Do semantic priming effects correlate with sensory gating in schizophrenia?. Biological Psychiatry. 1996;39:821–824
  39. Waldo MC, Myles-Worsley M, Madison A, Byerley W, Freedman R. Sensory gating deficits in parents of schizophrenics. American Journal of Medical Genetics. 1995;60:506–511
  40. Weltgesundheitsorganisation. Internationale Klassifikation psychischer Störungen 10th revision. Bern: Verlag Hans Huber; 1991;

PII: S0165-1781(04)00013-7

doi: 10.1016/j.psychres.2004.01.004

Psychiatry Research
Volume 125, Issue 3 , Pages 237-245 , 15 March 2004

Article Tools

* Image Usage & Resolution